Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Hematology
 Disease Category: Neutropenia
Location: United States, ND

Trial Information

A study for patients with breast cancer who are eligible for chemotherapy. Neulasta® will also be used in this study as a comparator to the investigational medication for the treatment of Neutropenia

A study of an investigational medication to determine if it is effective when given to patients with cancer who are also receiving Taxotere, Adriamycin and Cytoxan (TAC) to treat their breast cancer. Neulasta® will also be used in this study as a comparator to the investigational medication for the treatment of Neutropenia

Patient Inclusion Criteria:

  • Women of 18 years or older with histologically proven breast cancer who are eligible for six cycles of neoadjuvant or adjuvant treatment with TAC chemotherapy.
  • Patients with histologically proven breast cancer, eligible for neoadjuvant or adjuvant TAC chemotherapy.
  • Women ≥ 18 years of age

Patient Exclusion Criteria:

  • Concurrent or prior radiotherapy within four weeks of randomization
  • Concurrent or prior chemotherapy for breast cancer
  • Concurrent or prior anti-cancer treatment for breast cancer such as endocrine therapy, immunotherapy, monoclonal antibodies, and/or biological therapy

Joan Galbraith, Manager of Clinical Research Services
St. Alexius Medical Center
1310 East Main Ave., Suite 203
Bismarck, ND 58501
Phone: 701-530-6950
Fax: 701-530-6975
Email: jgalbraith@primecare.org

View Map

Research Center Information: St. Alexius Medical Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.